US Patent Issued to SHENZHEN PROFOUND VIEW PHARMACEUTICAL TECHNOLOGY on Jan. 27 for "Treatment of adverse effects caused by atypical antipsychotics" (Chinese Inventor)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,378, issued on Jan. 27, was assigned to SHENZHEN PROFOUND VIEW PHARMACEUTICAL TECHNOLOGY Co. LTD. (Shenzhen, China).

"Treatment of adverse effects caused by atypical antipsychotics" was invented by Taolei Sun (Wuhan, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Ligand-bound gold clusters and compositions comprising the ligand-bound gold clusters are used for treating adverse effects caused by atypical antipsychotics and manufacturing a medicament for treatment of adverse effects caused by atypical antipsychotics. Methods for treating adverse effects caused by atypical antipsychotics."

The patent was filed on May 10, 2020, under Application ...